PK MED is a pre-clinical stage biotech company specializing in precision drug delivery & tissue regeneration. Our purpose is to create innovative implants addressing unmet medical needs. Our unique approach to product development leverages our expertise in drug reformulation & repurposing, drug delivery, biomaterials design and technology innovations. PK MED is a company founded by Truffle Capital, the only European BioMedTech fund to support its portfolio companies from creation to commercial success.